Liqrev
Payments companies reported to CMS as associated with Liqrev. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Liqrev, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Liqrev
These are the largest totals companies reported as associated with Liqrev. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Lai | Daly City, CA | Internal Medicine | $420.41 |
| Kevin Wong | Daly City, CA | Internal Medicine | $369.81 |
| Shashwati Kale | San Jose, CA | Family Medicine | $296.39 |
| Larry Neuman | New York, NY | Internal Medicine | $274.23 |
| Navdeep Bamrah | San Jose, CA | Family | $219.91 |
| Shannon Donovan | Nashville, TN | Family | $200.00 |
| Bina Raghavan | San Jose, CA | Medical | $179.84 |
| Susan Hoffman | Palo Alto, CA | Internal Medicine | $169.02 |
| Kathryn Renschler | Palo Alto, CA | Internal Medicine | $167.74 |
| Jeffrey Croke | Palo Alto, CA | Internal Medicine | $167.23 |
Prescribed Liqrev?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.